MIMETAS vs StemoniX
StemoniX
Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research
1 employees · est. 2014 · Maple Grove, United States
MIMETAS is the older company (2013 vs 2014); MIMETAS is the larger of the two.
Side-by-Side Comparison
| Metric | MIMETAS | StemoniX |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2014 |
| Headquarters | ||
| Headquarters | The Netherlands | Maple Grove, United States |
| Employees | ||
| Employees | 93 larger | 1 |
| Industry | ||
| Industry | Biotechnology, Health Care, Information Technology | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Grant | Convertible Note |
| Total Funding | ||
| Total Funding | $31.91M | $33.21M |
| Funding Rounds | ||
| Funding Rounds | 5 | 11 |
| Services | ||
| Services | CRO Services, Training, Product Development, AI/Automation, Disease Mechanism Understanding, Drug Efficacy and Safety Testing, Target Discovery and Validation, Compound Prioritization and Derisking | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Companies, Academic Researchers, Healthcare Researchers, Regulatory Agencies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Organ-on-a-Chip3D Human Disease ModelsPredictive ToxicologyMicrofluidicsCell-based AssaysHigh-throughput Screening +9 | Stem Cell TechnologiesDrug DiscoveryPersonalized MedicineIPS CellsCardiomyocytesNeurons +8 |
| Website | ||
| Website | mimetas.com | stemonix.com |
About MIMETAS
MIMETAS, founded in 2013 and headquartered in The Netherlands, operates at the intersection of Biotechnology, Health Care, Information Technology, and VR/AR. The company is renowned for its slogan: Human Tissue Models for Better Therapies. MIMETAS specializes in developing cutting-edge, screenable 3...
About StemoniX
StemoniX is a biotechnology startup based in the United States, founded in 2014, focusing on accelerating the discovery of new medicines through the development and scalable manufacture of human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and developme...
Also comparing in this category
Comparing more than these two?
Get MIMETAS, StemoniX and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does MIMETAS compare?
A PDF of MIMETAS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare MIMETAS with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at MIMETAS on 8 Jun 2026, and StemoniX on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.